Flaxseed: grind it, bake it, expect a small effect

Whole flaxseed is mostly wasted as a source of omega-3. Healthy adults who ate 30 g of whole seed a day for three months saw no significant rise in blood alpha-linolenic acid, the omega-3 fat the seed is bought for, while the same seed milled, or pressed into oil, raised it within a month. That is the one instruction on this page that the trials agree on. The health results are smaller than the reputation. Pooled over 33 randomised trials with 2,427 people, flaxseed lowered systolic blood pressure by 3.2 mmHg and diastolic by 2.6 mmHg, with bigger drops at 30 g a day or more and in people who already had hypertension. Those trials fed everything from whole seed to oil and lignan extracts, and their results disagreed so widely that the average is a rough guide rather than a promise. In type 2 diabetes it lowered HbA1c, while weight, blood pressure and fasting glucose did not change overall. Fasting glucose fell only in the subgroups who started poorly controlled. LDL cholesterol, the reason many people add it, did not move overall in 16 trials in diabetics, although an earlier review saw a fall in the trials that used whole seed, so that question is open. In children with high LDL it went the wrong way: LDL did not fall, HDL dropped 15 percent and triglycerides rose 26 percent in four weeks. Raw ground seed also carries compounds that release cyanide. Baking removed them in the one study that measured it, and EU law now limits them in linseed for exactly that reason.

The numbers, per 100 g

How much is actually in it

• Across 8 USDA reference samples of ground flaxseed, total polyunsaturated fat ranged from 7.4 to 30.3 g per 100 g and calcium from 179 to 373 mg, so a single label number hides a fourfold spread in the fat that makes flaxseed worth eating. — 8 analytical samples of ground flaxseed, USDA Foundation Foods FDC 2262075 (n = 8 samples) Evidence E source
  Fatty acids, total polyunsaturated: mean 24.73 g/100 g, range 7.44 to 30.32; calcium 229.9 mg, range 179.0 to 373.0; copper 1.344 mg, range 0.96 to 2.12; monounsaturated 5.944 g, range 2.21 to 6.87

What a real portion looks like

• 10 g a day of milled flaxseed was enough to raise blood alpha-linolenic acid and lignans in 34 healthy adults over 30 days. EPA rose only at 30 g a day, and 40 g a day caused no adverse events but also no cholesterol change. — 34 healthy adults aged 18 to 49, one muffin daily with 10, 20, 30 or 40 g milled flaxseed, 30 days (n = 34) Evidence B source
  Plasma ALA up at 10, 30 and 40 g/day (P < 0.01), not at 20 g (P = 0.10), no dose-response; EPA up only at 30 g/day (P = 0.047); enterolignans up at all doses; no adverse events, no cholesterol change
• Muffins with 20 or 30 g of milled flaxseed kept their alpha-linolenic acid, lignan and sensory profile through 6 months at -20 C, but consumers rated any flax addition less acceptable and 30 g the least. — banana and cinnamon muffins with 0, 20 or 30 g flaxseed, frozen 1 and 6 months, rated by clinical trial participants and by consumers Evidence B source
  ALA and secoisolariciresinol diglucoside higher at 30 g than 20 g; storage at -20 C for 6 months did not appreciably change attributes or acceptability; consumer acceptability fell with any flax, lowest at 30 g

What your body absorbs

• Whole flaxseed eaten at 30 g a day for 3 months produced no significant rise in plasma alpha-linolenic acid, while the same seed milled, or its oil, did within 1 month, and neither form raised EPA or DHA. — healthy men and women, 30 g of whole or milled seed or 6 g ALA as oil baked into muffins, 3 months Evidence B source
  Plasma ALA up in oil and milled groups (P = 0.005), oil higher than milled (P = 0.004); whole seed no significant rise; no EPA or DHA rise; no change in cholesterol, TG or platelet aggregation
• People aged 45 to 69 absorbed alpha-linolenic acid from 30 g of ground flaxseed or its oil about as well as 18 to 29 year olds over 4 weeks, and the higher fibre load caused no side effects in the older group. — adults aged 18 to 29 or 45 to 69, 6 g ALA a day as 30 g ground flaxseed or as flaxseed oil, 4 weeks, double blind Evidence B source
  Plasma ALA and EPA rose with oil in both age groups; ground seed raised ALA significantly only in the younger group with the same trend in the older; no change in cholesterol; TG fell only in younger subjects
• When flaxseed foods made up 20 percent of energy for 4 weeks in 80 volunteers, serum thiocyanate and blood cadmium stayed within reference values and serum enterolactone doubled. — 80 volunteers, double-blind crossover, meals with 1.3 g/100 g ground flaxseed and 5 g/100 g flaxseed oil for 4 weeks against unsupplemented foods, 4-week washout (n = 80) Evidence B source
  No change in basic laboratory values or blood lipids; serum ALA, EPA and DPA up; enterolactone doubled; thiocyanate and cadmium within reference and no difference between diets

What cooking and storage change

• 50 g of raw ground flaxseed a day for 4 weeks doubled urinary thiocyanate in healthy women, yet the cyanogenic glycosides were undetectable in baked muffins with 150 g flaxseed per kg, and LDL fell 18 percent. — healthy women eating 50 g raw ground flaxseed a day (12 to 13 percent of energy) for 4 weeks; test meals and baked muffins analysed Evidence C source
  Urinary thiocyanate 2.2-fold; total cholesterol -9%, LDL -18%; postprandial glucose -27% with 50 g carbohydrate from flaxseed or 25 g mucilage; cyanogenic glycosides highest in extracted mucilage, not detected in baked muffins
• EU law sets maximum levels for hydrocyanic acid in linseed because, in the regulator's words, eating ground linseed raw exposes a person to more cyanide than eating it whole or heat-treated. — linseed placed on the EU market, including ground, milled, cracked and chopped seed sold to consumers Evidence E source
  Regulation (EU) 2022/1364 amends the contaminant limits for hydrocyanic acid in linseed (Annex rows 8.3.1 and 8.3.2) and exempts small consumer packs labelled Only to be used for cooking and baking. Do not consume raw!; the numeric mg/kg limits did not render in our fetch

What it does to your health

• Pooled over 33 randomised trials with 2,427 participants, flaxseed lowered systolic blood pressure by 3.2 mmHg and diastolic by 2.6 mmHg, with larger drops at 30 g a day or more, beyond 20 weeks, and in people with hypertension. — 2,427 adults in 33 randomised trials (43 treatment arms) of flaxseed products, searched to July 2022 (n = 2427) Evidence A source
  SBP WMD -3.19 mmHg (-4.15 to -2.24); DBP WMD -2.61 mmHg (-3.27 to -1.94); larger at 30 g/day or more, over 20 weeks, BMI 25 to 30, hypertension

Safety, limits and interactions

• In a review of 1,491 documented supplement-drug interaction pairs, flaxseed was one of the three supplements with the largest number of documented contraindications, alongside echinacea and yohimbe. — 85 primary papers, six books and two websites covering 213 supplement entities and 509 medications (n = 1491 pairs) Evidence C source
  Flaxseed among the three entities with most documented contraindications; the most frequent contraindication categories were gastrointestinal (16.4%), neurological (14.5%) and renal or genitourinary (12.5%)

What people believe that the data does not support

• The EU allows food labels to say that alpha-linolenic acid, the fat flaxseed is richest in, contributes to the maintenance of normal blood cholesterol levels. — EU food labelling Evidence E source
  Claim POL-HC-6327 for alpha-linolenic acid carries the status Authorised
• The claim that flaxseed oil promotes heart health was refused in the EU register, even though its main fatty acid carries an authorised cholesterol claim. — EU food labelling Evidence E source
  Claim POL-HC-7106 for flaxseed oil and alpha-linolenic acid carries the status Non-authorised; two further flaxseed claims (skin barrier, mood) are also non-authorised

Who this works differently for

• In people with metabolic disease, 18 randomised trials with 1,209 participants pooled in 2025 gave a 4.3 mmHg drop in systolic and 2.5 mmHg in diastolic blood pressure with flaxseed. — 1,209 adults with metabolic diseases in 18 randomised trials (22 treatment arms) (n = 1209) Evidence A source
  SBP WMD -4.30 mmHg (-6.64 to -1.96); DBP WMD -2.50 mmHg (-3.88 to -1.12); larger effects at 10 to 20 weeks, with whole flaxseed, BMI 25 to 30 and hypertension
• Across 13 randomised trials in type 2 diabetes, flaxseed lowered HbA1c, while weight, blood pressure, fasting glucose and lipids did not change overall. Fasting glucose fell only in subgroups whose baseline fasting glucose was 8.0 mmol/L or more or whose HbA1c was 7.0 percent or more. — adults with type 2 diabetes in 13 randomised controlled trials, searched to March 2022 (n = 13 trials) Evidence A source
  HbA1c reduced vs control; fasting glucose reduced only when baseline FBG 8.0 mmol/L or more or HbA1c 7.0 percent or more; whole flaxseed subgroup raised HDL and lowered TC or LDL
• In 16 trials with 1,136 diabetic patients, flaxseed reduced weight, waist circumference and triglycerides, but not BMI, blood pressure, total, LDL or HDL cholesterol. — 1,136 diabetic patients in 16 randomised trials, searched to June 2024 (n = 1136) Evidence A source
  Weight SMD 0.81, waist SMD 1.54, triglyceride SMD 0.56 improved; BMI, SBP, DBP, TC, LDL, HDL not significant
• In 6 randomised trials of patients with coronary artery disease, flaxseed lowered fasting glucose by 8.4 mg/dL and hs-CRP by 1.35 mg/L, left weight and most lipids unchanged, and cut triglycerides by 18 mg/dL only after a sensitivity analysis. — 309 patients with coronary artery disease in 6 randomised controlled trials published 2017 to 2022 (n = 309) Evidence A source
  FBG WMD -8.35 mg/dL (-15.01 to -1.69); hs-CRP WMD -1.35 mg/L (-1.93 to -0.77); TG -18.39 mg/dL (-35.02 to -1.75) after sensitivity analysis; weight, BMI, HDL, LDL, TC null
• In 32 children aged 8 to 18 with high LDL, 30 g of ground flaxseed a day for 4 weeks lowered HDL by 15 percent and raised triglycerides by 26 percent, without a significant fall in LDL. — 32 children and adolescents aged 8 to 18 with LDL 135 to below 193 mg/dL at a tertiary dyslipidemia clinic, 4 weeks, blinded placebo control (n = 32) Evidence B source
  HDL -7.35 mg/dL (-15%, -24 to -6%); TG +29.23 mg/dL (+26%, +4 to +48%); LDL -6.96 mg/dL not significant; TC, BMI z-score, calories unchanged; no safety concerns

The bottom line

Buy it ground, or grind it yourself, and cook with it. In 34 healthy adults, 10 g a day of milled flaxseed was enough to raise blood alpha-linolenic acid and lignans, the plant compounds flaxseed is known for, within 30 days, and 40 g a day, baked into a muffin, caused no adverse events. Fifty grams a day of raw ground seed for four weeks doubled thiocyanate in the urine of healthy women, which is the trace cyanide leaves behind. The same compounds could not be detected in baked muffins. That 1993 study also saw LDL fall 18 percent, but it had no randomised control group, so it settles nothing about cholesterol. EU rules exempt small consumer packs from the hydrocyanic-acid limit only when they are labelled only to be used for cooking and baking, do not consume raw. Freezing baked goods is not a problem. Muffins with 20 or 30 g of flaxseed kept their ALA and lignans for six months at minus 20 C, though consumers liked them less the more flax went in. If you were hoping for fish oil effects, lower the expectation. In the trial that fed 30 g of milled seed for three months neither EPA nor DHA rose, and in the dose trial EPA rose only at 30 g a day. The authors of the age trial found no age effect on ALA absorption, though the rise in the older group from ground seed missed significance, and the extra fibre gave the older group no side effects. When flaxseed foods made up a fifth of all energy for four weeks in 80 volunteers, blood cadmium and thiocyanate stayed within reference values. The groups with a signal worth knowing: in people with metabolic disease, 18 trials pooled in 2025 gave a 4.3 mmHg drop in systolic pressure. In diabetic patients across 16 trials, weight, waist and triglycerides improved while BMI, blood pressure and cholesterol did not, although an earlier review of 13 trials saw no weight change at all. In 309 people with coronary artery disease, fasting glucose fell by 8.4 mg/dL and the inflammation marker hs-CRP by 1.35 mg/L, from six small trials. Now the cautions. In a review of 1,491 documented supplement and drug interaction pairs, flaxseed was one of the three supplements with the most contraindications on record, next to echinacea and yohimbe. That is a count of paperwork rather than of harm, the review does not say which conditions, and our own drug-label layer has no flaxseed row at all. So if you take any regular medication, the person who prescribed it is the one to ask, because this page cannot. Children with high LDL are the clearest case against: HDL down, triglycerides up, LDL unchanged. The heart-health claim for flaxseed oil was refused in the EU, while its main fatty acid, ALA, is allowed a claim about maintaining normal cholesterol. Both are regulator decisions, not trial results. And the bag itself varies. Across eight USDA reference samples of ground flaxseed, polyunsaturated fat ran from 7.4 to 30.3 g per 100 g, so the fat you are paying for can differ fourfold from one sample to the next.

Sources

1. flx-c1-17 · reference dataset
   USDA Foundation Foods 2262075 Flaxseed, ground — Fatty acids, total polyunsaturated 24.73 G, range 7.44–30.32 (median 26.79), 8 samples · Calcium, Ca 229.9 MG, range 179.0–373.0 (median 206.5), 8 samples · Copper, Cu 1.344 MG, range 0.96–2.12 (median 1.283), 8 samples
   USDA FoodData Central, Foundation Foods, release 2026-04-30 · checked 2026-09-23
2. flx-c1-08 · randomised controlled dose-ranging trial
   Plasma ALA concentrations increased with all flaxseed doses (P < 0.01), except the 20 g/day dose (P = 0.10), yet there was no significant dose-dependent response (P = 0.81). Only with the 30 g/day diet were n-3 polyunsaturated fatty acids (P = 0.007), and eicosapentaenoic acid (EPA) (P = 0.047) increased from baseline values. ... Flaxseed was well tolerated, even at the highest dose, as there were no reported adverse events, changes in cholesterol, platelet aggregation or urinary 11-dehydro-thromboxane B2.
   Eur J Nutr, 2016 · checked 2026-09-23
3. flx-c1-12 · randomised controlled crossover trial with sensory and chemical analysis
   Alpha-linolenic acid and secoisolariciresinol diglucoside were significantly increased when flax was increased from 20 to 30 g. ... Consumers reported significantly decreased acceptability when flax at any level was added to muffins, with 30 g the least acceptable. ... Neither flavoring nor storage at -20 °C for 6 months appreciably changed muffin attributes or acceptability.
   J Sci Food Agric, 2019 · checked 2026-09-23
4. flx-c1-06 · randomised controlled comparative trial of three flaxseed forms
   Flaxseed ingestion over a 1 month period resulted in significant (P = 0.005) increases in plasma ALA levels in the flaxseed oil and the milled flaxseed supplemented groups. The former group had significantly (P = 0.004) higher ALA levels than the milled flaxseed group. The subjects supplemented with whole flaxseed did not achieve a significant (P > 0.05) increase in plasma ALA levels. ... However, no significant increase was detected in plasma eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) levels in any of the flax-fed groups.
   J Am Coll Nutr, 2008 · checked 2026-09-23
5. flx-c1-07 · randomised double-blind controlled trial
   Subjects who received ground flaxseed in the 18-29-year-old group showed a statistically significant increase in their plasma ALA levels, and although there was a trend in the same direction for the 45-69-year-old subjects, this did not achieve statistical significance. ... Subject age does not seem to be a major determining factor in influencing ALA absorption from a flaxseed-supplemented diet nor in the metabolism of ALA to EPA in the groups fed flaxseed oil. Concerns about side effects in older subjects administered a higher fiber load in a flaxseed-supplemented diet are not justified.
   Eur J Clin Nutr, 2009 · checked 2026-09-23
6. flx-c1-11 · randomised double-blind crossover clinical trial
   The percentage of flaxseed supplemented test food out of total dietary intake was 20% of energy. ... No significant changes were observed in the basic laboratory values or in blood lipids. There was a significant increase in serum alpha-linolenic acid, eicosapentaenoic acid and docosapentaenoic acid. Serum enterolactone concentration was doubled during flaxseed supplementation. Serum thiocyanate and blood cadmium values did not exceed reference values and there was no difference between the diets.
   Eur J Clin Nutr, 2002 · checked 2026-09-23
7. flx-c1-10 · non-randomised controlled feeding study in healthy women with food chemistry analyses
   Flaxseed raised alpha-linolenic acid and long-chain n-3 fatty acids in both plasma and erythrocyte lipids, as well as raising urinary thiocyanate excretion 2.2-fold. Flaxseed also lowered serum total cholesterol by 9% and low-density-lipoprotein-cholesterol by 18%. ... Cyanogenic glycosides (linamarin, linustatin, neolinustatin) were highest in extracted flaxseed mucilage but were not detected in baked muffins containing 150 g flaxseed/kg.
   Br J Nutr, 1993 · checked 2026-09-23
8. flx-c1-16 · regulation
   When ground linseed as such is consumed, the bioavailability of hydrocyanic acid and human exposure levels to it are higher than when whole linseeds are consumed or when they are heat-treated.
   Commission Regulation (EU) 2022/1364, Official Journal, 2022 · checked 2026-09-23
9. flx-c1-01 · systematic review and dose-response meta-analysis of randomised clinical trials
   Meta-analysis of 33 trials (comprising 43 treatment arms) with 2427 participants revealed significant reductions in both systolic (WMD: -3.19 mmHg; 95% CI: -4.15 to -2.24, p < 0.001; I2 = 92.5%, p < 0.001) and diastolic blood pressure (WMD = -2.61 mmHg; 95% CI: -3.27, -1.94, p < 0.001; I2 = 94.1%, p < 0.001) following flaxseed supplementation. Greater effects on SBP and DBP were found in trials with an intervention duration of >20 weeks, ≥30 g day-1 of flaxseed, subjects with BMI 25-30 kg m-2, and in patients with hypertension.
   Food Funct, 2023 · checked 2026-09-23
10. flx-c1-13 · structured literature review of documented interactions and contraindications
    While 85 primary literatures, six books and two web sites were reviewed for a total of 1,491 unique pairs of HDS-drug interactions, 213 HDS entities and 509 medications were involved. ... Of the 152 identified HDS contraindications, the most frequent involved gastrointestinal (16.4%), neurological (14.5%), and renal/genitourinary diseases (12.5%). Flaxseed, echinacea, and yohimbe had the largest number of documented contraindications.
    Int J Clin Pract, 2012 · checked 2026-09-23
11. flx-c1-14 · regulatory register entry
    POL-HC-6327 Alpha-linolenic acid (ALA) ALA contributes to the maintenance of normal blood cholesterol levels Authorised
    EU Register on nutrition and health claims, claim POL-HC-6327, snapshot 2026-09-21 · checked 2026-09-23
12. flx-c1-15 · regulatory register entry
    POL-HC-7106 Flaxseed oil/alpha-linoleic acid Promotes heart health Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7106, snapshot 2026-09-21 · checked 2026-09-23
13. flx-c1-02 · systematic review and meta-analysis of randomised controlled trials with GRADE
    Meta-analysis of 18 trials (comprising 22 treatment arms) with 1,209 participants revealed significant reductions in both systolic (WMD: -4.30 mmHg; 95% CI: -6.64 to -1.96, p < 0.001; I2 = 95.2%, p < 0.001) and diastolic blood pressure (WMD = -2.50 mmHg; 95% CI: -3.88, -1.12, p < 0.001; I2 = 95.0%, p < 0.001) following flaxseed supplementation.
    J Diabetes Metab Disord, 2025 · checked 2026-09-23
14. flx-c1-03 · systematic review and meta-analysis of randomised controlled trials
    A total of 13 studies were included, and the results showed that flaxseed supplementation significantly reduced hemoglobin A1c (HbA1c) in participants with T2DM compared with the control group. In contrast, it had no effects on body weight, body mass index, blood pressure, fasting blood glucose (FBG), homeostatic model assessment for insulin resistance, quantitative insulin sensitivity check index, and lipid parameters. In the subgroup analyses, FBG was significantly reduced with supplementation of flaxseed in participants with baseline FBG ≥8.0 mmol/L or baseline HbA1c ≥7.0%.
    Nutr Res, 2023 · checked 2026-09-23
15. flx-c1-04 · GRADE-assessed systematic review and meta-analysis of randomised controlled trials
    Meta-analysis of 16 trials with 1136 participants indicated significant improvements in weight (SMD: 0.81; 95 % CI: 1.54 to -0.09, p = 0.028; I2 = 88.7 %, p < 0.001), waist circumference (SMD: 1.54; 95 % CI: 2.77 to -0.31, p = 0.002; I2 = 85.3 %, p < 0.001), and triglyceride (SMD: 0.56; 95 % CI: 1.02 to -0.10, p = 0.016; I2 = 87.4 %, p < 0.001), but not BMI (SMD: 0.63; 95 % CI: 1.28 to 0.02, p = 0.058; I2 = 87.9 %, p = 0.005), systolic blood pressure (SMD: 0.50; 95 % CI: 1.25, 0.25, p = 0.193; I2 = 87.6 %, p < 0.001), diastolic blood pressure (SMD: 0.74; 95 % CI: 1.51, 0.03, p = 0.060; I2 = 88.1 %, p < 0.001), total cholesterol (SMD: 0.43; 95 % CI: 0.99 to 0.12, p = 0.128; I2 = 93.6 %, p < 0.001), low-density lipoprotein cholesterol (SMD: 0.09; 95 % CI: 0.87 to 0.70, p = 0.830; I2 = 96.3 %, p < 0.001), and high-density lipoprotein cholesterol (SMD: 0.08; 95 % CI: 0.30 to 0.46, p = 0.673; I2 = 87.2 %, p < 0.001).
    Diabetes Metab Syndr, 2025 · checked 2026-09-23
16. flx-c1-05 · systematic review and meta-analysis of randomised controlled trials
    Of the 428 citations, six RCTs were included. The pooled results did not show significant changes in the WMD of lipid factors (high-density lipoprotein cholesterol, triglycerides (TG), low-density lipoprotein cholesterol, and total cholesterol) following flaxseed intake. However, after performing a sensitivity analysis to determine the source of heterogeneity, flaxseed supplementation resulted in a significant decrease in TG levels (WMD = -18.39 mg/dL; 95% CI: -35.02, -1.75). Moreover, no significant differences were observed in either weight or BMI following flaxseed intake. However, the circulating levels of fasting blood glucose (WMD = -8.35 mg/dL; 95% CI: -15.01, -1.69, p = .01) and hs-CRP (WMD = -1.35 mg/L; 95% CI: -1.93, -0.77, p < .01) significantly decreased after the intervention.
    Clin Cardiol, 2024 · checked 2026-09-23
17. flx-c1-09 · placebo-controlled, blinded, randomised clinical trial
    Dietary flaxseed supplementation resulted in an attributable decrease of -7.35 mg/dL (-0.19 mmol/L) in high-density lipoprotein cholesterol (95% CI, -3.09 to -11.60 mg/dL[-0.08 to -0.30 mmol/L]; relative: -15%, 95% CI, -24% to -6%; P = .001), an increase of 29.23 mg/dL (+0.33 mmol/L) in triglycerides (95% CI, 4.43 to 53.14 mg/dL [+0.05 to +0.60 mmol/L]; relative: +26%, 95% CI, +4% to +48%; P = .02)
    JAMA Pediatr, 2013 · checked 2026-09-23